tolterodine tartrate
PolandDrugs containing this active substance
-
The medicine is used to treat the symptoms of overactive bladder syndrome, such as sudden and/or frequent urination and urge incontinence.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
-
It is used to treat symptoms of overactive bladder syndrome, such as difficulty controlling urination, a sudden urge to urinate, or frequent urination.
Form: tablets, film-coated
Active substance Dosage tolterodine tartrate 1 mg ATC: G04BD07
Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.
-
It is used in the treatment of symptoms of overactive bladder syndrome. It helps people who have difficulty controlling urination, experience a sudden urge to go to the toilet, or use the toilet very frequently.
Form: tablets, film-coated
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.
-
It is used to treat symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or inability to control urination.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
Manufacturer: Pharmathen International S.A.
-
It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or urinary incontinence.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
Manufacturer: Pharmathen International S.A.
-
It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to use the toilet quickly, frequent use of the toilet, or an inability to control urination.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
Manufacturer: Pharmathen International S.A.
-
It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to urinate, frequent urination, or urinary incontinence.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
Manufacturer: Pharmathen S.A.
-
It is used to treat the symptoms of an overactive bladder, which is a situation where the patient cannot control urination or feels a sudden urge to use the toilet frequently.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
Manufacturer: Pharmathen International S.A.
-
It is used to treat symptoms of an overactive bladder, such as a sudden urge to urinate, frequent urination, or loss of bladder control.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
Manufacturer: Pharmathen International S.A.
-
It is used to treat symptoms of overactive bladder syndrome, such as urinary incontinence, a sudden urge to urinate quickly, or increased frequency of urination.
Form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
Manufacturer: Pharmaten International S.A.